| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 109.39M | 122.58M | 153.94M | 165.83M | 147.01M |
| Gross Profit | 54.98M | 30.35M | 81.59M | 96.56M | 93.01M |
| EBITDA | 29.81M | 46.85M | 48.45M | 62.25M | 64.73M |
| Net Income | -3.40M | 2.16M | 1.41M | 11.87M | 10.05M |
Balance Sheet | |||||
| Total Assets | 314.10M | 316.99M | 306.07M | 279.52M | 239.73M |
| Cash, Cash Equivalents and Short-Term Investments | 1.38M | 71.01M | 6.26M | 2.03M | 10.55M |
| Total Debt | 137.39M | 130.25M | 150.28M | 110.24M | 77.05M |
| Total Liabilities | 174.08M | 173.57M | 178.71M | 154.67M | 126.76M |
| Stockholders Equity | 140.02M | 143.42M | 127.36M | 124.85M | 112.98M |
Cash Flow | |||||
| Free Cash Flow | 14.15M | 32.47M | 16.06M | 33.41M | 45.97M |
| Operating Cash Flow | 14.46M | 32.88M | 17.34M | 36.59M | 47.58M |
| Investing Cash Flow | 472.00K | 254.00K | -1.27M | -34.11M | -1.07M |
| Financing Cash Flow | -10.84M | -38.27M | -16.05M | -14.20M | -81.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$140.00M | 5.19 | 10.12% | ― | 14.65% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$197.82M | 53.04 | 0.62% | 2.34% | -48.30% | -75.98% | |
62 Neutral | HK$176.54M | 1.77 | 9.68% | ― | 5.34% | 43.91% | |
58 Neutral | HK$907.20M | 18.00 | -3.78% | ― | -0.28% | -469.70% | |
38 Underperform | HK$46.33M | -2.03 | 148.20% | ― | 1.43% | -83.97% |